ea0077oc2.1 | Endocrine Cancer and Late Effects | SFEBES2021
Kurzawinski Tom
, Hubbard Jonathan
, Abdel Aziz Tarek
, Butler Colin
, Brain Caroline
, Beale Tim
, Gaze Mark
, Ross Emma
, Stoneham Sarah
, Hulse Tony
, Simpson Kate
, Proctor Ian
, Cattaneo Elene
, Gevers Evelien
, Marshall Lynley
, Shankar Ananth
Background: Patients with Multiple Endocrine Neoplasia type 2 (MEN2) without previous family history often present late with advanced Medullary Thyroid Cancer (MTC). Surgery is not always curative but RET tyrosine kinase pathway is a potential target for molecular treatment for progressive MTC.Methods: Retrospective review of clinical, genetic, biochemical (calcitonin, CEA) and imaging (US, CT/MRI, Gallium Dotate) data of children with MEN2 who developed...